IFNG and tuberculosis: There is evidence relating the IFN-γ production with reduced disease burden in experimental disease [3] and in humans [4–6], but the in vitro IFN-γ production against mycobacterial antigen(s) and the expansion of IFN-γ-producing antigen-specific cells do not always correlate with vaccine-induced protection against TB [7,8].